These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 7571410)
1. Effects of antibody to the influenza A virus M2 protein on M2 surface expression and virus assembly. Hughey PG; Roberts PC; Holsinger LJ; Zebedee SL; Lamb RA; Compans RW Virology; 1995 Oct; 212(2):411-21. PubMed ID: 7571410 [TBL] [Abstract][Full Text] [Related]
2. The M1 and M2 proteins of influenza A virus are important determinants in filamentous particle formation. Roberts PC; Lamb RA; Compans RW Virology; 1998 Jan; 240(1):127-37. PubMed ID: 9448697 [TBL] [Abstract][Full Text] [Related]
3. Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins. Latham T; Galarza JM J Virol; 2001 Jul; 75(13):6154-65. PubMed ID: 11390617 [TBL] [Abstract][Full Text] [Related]
4. Growth restriction of influenza A virus by M2 protein antibody is genetically linked to the M1 protein. Zebedee SL; Lamb RA Proc Natl Acad Sci U S A; 1989 Feb; 86(3):1061-5. PubMed ID: 2915973 [TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibody recognizing SLLTEVET epitope of M2 protein potently inhibited the replication of influenza A viruses in MDCK cells. Wang Y; Zhou L; Shi H; Xu H; Yao H; Xi XG; Toyoda T; Wang X; Wang T Biochem Biophys Res Commun; 2009 Jul; 385(1):118-22. PubMed ID: 19410554 [TBL] [Abstract][Full Text] [Related]
7. Human single chain monoclonal antibody that recognizes matrix protein of heterologous influenza A virus subtypes. Poungpair O; Chaicumpa W; Kulkeaw K; Maneewatch S; Thueng-in K; Srimanote P; Tongtawe P; Songserm T; Lekcharoensuk P; Tapchaisri P J Virol Methods; 2009 Jul; 159(1):105-11. PubMed ID: 19442853 [TBL] [Abstract][Full Text] [Related]
8. The M1 matrix protein controls the filamentous phenotype of influenza A virus. Elleman CJ; Barclay WS Virology; 2004 Mar; 321(1):144-53. PubMed ID: 15033573 [TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibody, but not synthetic peptide, targeting the ectodomain of influenza B virus M2 proton channel has antiviral activity. Wang Y; Xu H; Wu N; Shi H; Wang X; Wang T New Microbiol; 2010 Oct; 33(4):311-7. PubMed ID: 21213589 [TBL] [Abstract][Full Text] [Related]
10. The cold adapted and temperature sensitive influenza A/Ann Arbor/6/60 virus, the master donor virus for live attenuated influenza vaccines, has multiple defects in replication at the restrictive temperature. Chan W; Zhou H; Kemble G; Jin H Virology; 2008 Oct; 380(2):304-11. PubMed ID: 18768193 [TBL] [Abstract][Full Text] [Related]
11. A humanized anti-M2 scFv shows protective in vitro activity against influenza. Gabbard J; Velappan N; Di Niro R; Schmidt J; Jones CA; Tompkins SM; Bradbury AR Protein Eng Des Sel; 2009 Mar; 22(3):189-98. PubMed ID: 19054791 [TBL] [Abstract][Full Text] [Related]
12. The antibody responses to swine influenza virus (SIV) recombinant matrix 1 (rM1), matrix 2 (M2), and hemagglutinin (HA) proteins in pigs with different SIV exposure. Kitikoon P; Strait EL; Thacker EL Vet Microbiol; 2008 Jan; 126(1-3):51-62. PubMed ID: 17719187 [TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of an M2-specific monoclonal antibody on different strains of influenza A virus. Muto NA; Yoshida R; Suzuki T; Kobayashi S; Ozaki H; Fujikura D; Manzoor R; Muramatsu M; Takada A; Kimura T; Sawa H Jpn J Vet Res; 2012 Aug; 60(2-3):71-83. PubMed ID: 23094582 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein. Wang R; Song A; Levin J; Dennis D; Zhang NJ; Yoshida H; Koriazova L; Madura L; Shapiro L; Matsumoto A; Yoshida H; Mikayama T; Kubo RT; Sarawar S; Cheroutre H; Kato S Antiviral Res; 2008 Nov; 80(2):168-77. PubMed ID: 18598723 [TBL] [Abstract][Full Text] [Related]
15. Hemagglutinin 1-specific immunoglobulin G and Fab molecules mediate postattachment neutralization of influenza A virus by inhibition of an early fusion event. Edwards MJ; Dimmock NJ J Virol; 2001 Nov; 75(21):10208-18. PubMed ID: 11581389 [TBL] [Abstract][Full Text] [Related]
16. IgG neutralization of type A influenza viruses and the inhibition of the endosomal fusion stage of the infectious pathway in BHK cells. Outlaw MC; Dimmock NJ Virology; 1993 Aug; 195(2):413-21. PubMed ID: 8337821 [TBL] [Abstract][Full Text] [Related]
17. Reverse genetics studies on the filamentous morphology of influenza A virus. Bourmakina SV; GarcĂa-Sastre A J Gen Virol; 2003 Mar; 84(Pt 3):517-527. PubMed ID: 12604801 [TBL] [Abstract][Full Text] [Related]
19. Influenza virus assembly and budding in raft-derived microdomains: a quantitative analysis of the surface distribution of HA, NA and M2 proteins. Leser GP; Lamb RA Virology; 2005 Nov; 342(2):215-27. PubMed ID: 16249012 [TBL] [Abstract][Full Text] [Related]
20. Introduction of a temperature-sensitive phenotype into influenza A/WSN/33 virus by altering the basic amino acid domain of influenza virus matrix protein. Liu T; Ye Z J Virol; 2004 Sep; 78(18):9585-91. PubMed ID: 15331690 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]